Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | NT5E | P21589 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1746338 | 1.00 | — | — | |
| SCHEMBL25726143 | 0.87 | POLB (0.33) | POLBTSHRKMT2A | |
| SCHEMBL1650338 | 0.86 | — | — | |
| SCHEMBL1335069 | 0.86 | — | — | |
| SCHEMBL2778744 | 0.85 | POLB (0.43) | POLBTSHRKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL28326239 | 0.85 | CA1 (0.32) | POLBTSHRKMT2ACA5ACA5B | |
| SCHEMBL2590451 | 0.83 | CA1 (0.48) | POLBTSHRKMT2ACA1CA2 | |
| SCHEMBL3681074 | 0.83 | CA1 (0.55) | POLBTSHRKMT2ACA1CA2 | |
| SCHEMBL917445 | 0.83 | CA1 (0.55) | POLBTSHRKMT2ACA1CA2 | |
| SCHEMBL15247350 | 0.83 | CA1 (0.55) | POLBTSHRKMT2ACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110261601-B | Homocysteine detection kit | 三诺生物传感股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-111433308-A | Multi-component adhesive composition and use thereof | 博斯蒂克股份公司 | 2020-07-17 | — | — | CN | claimed |
| US-8858906-B2 | Process for removal of carbon dioxide from a gas | SHELL OIL COMPANY (US) | 2014-10-14 | — | — | US | claimed |
| US-8269002-B2 | Pyrimidine sulphonamide derivatives as chemokine receptor modulators | ASTRAZENECA AB (SE) | 2012-09-18 | — | — | US | claimed |
| CN-115704003-B | Lactobacillus plantarum TCI837 and application thereof and iron supplementing composition | 百岳特生物技术（上海）有限公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-117233371-A | Method for detecting ethylene content and distribution of plants | 佛山科学技术学院 | 2023-12-15 | — | — | CN | disclosed |
| CN-117004573-A | Immune cell containing tumor antigen recognition receptor and application thereof | 苏州康聚生物科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116925979-A | Bacillus bailii and application thereof in promoting plant growth | 中国林业科学研究院华北林业实验中心 | 2023-10-24 | — | — | CN | disclosed |
| CN-114317509-B | Cellobiose epimerase mutant and application thereof | 江南大学 | 2023-07-25 | — | — | CN | disclosed |
| CN-111433308-B | Multi-component adhesive composition and use thereof | 博斯蒂克股份公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-113092786-B | Buffer solution and application thereof in central nervous system specific protein detection kit | 北京美联泰科生物技术有限公司 | 2021-12-24 | — | — | CN | disclosed |
| CN-109836398-B | Preparation method of special biological buffer-piperazine-diethylsulfonic acid 1.5Na salt | 荆楚理工学院 | 2021-08-17 | — | — | CN | disclosed |
| EP-2107930-A1 | PROCESS FOR REDUCING CARBON DIOXIDE EMISSION IN A POWER PLANT | Shell Internationale Research Maatschappij B.V. (NL) | 2009-10-14 | — | — | EP | disclosed |
| WO-2009112518-A1 | PROCESS FOR REMOVAL OF CARBON DIOXIDE FROM A GAS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2009-09-17 | — | — | WO | disclosed |
| WO-2009027491-A1 | PROCESS FOR REMOVAL OF HYDROGEN SULPHIDE AND CARBON DIOXIDE FROM AN ACID GAS STREAM | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2009-03-05 | — | — | WO | disclosed |
| WO-2008090168-A1 | PROCESS FOR REDUCING CARBON DIOXIDE EMISSION IN A POWER PLANT | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008090166-A1 | PROCESS FOR ENABLING CONSTANT POWER OUTPUT IN A POWER PLANT INTEGRATED WITH A CARBON DIOXIDE CAPTURE UNIT | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008090167-A1 | PROCESS FOR PRODUCING A PRESSURISED CO2 STREAM IN A POWER PLANT INTEGRATED WITH A CO2 CAPTURE UNIT | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2008-07-31 | — | — | WO | disclosed |
| US-20080096860-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | ASTRAZENECA AB (SE) | 2008-04-24 | — | — | US | disclosed |
| CN-101048401-A | Pyrimidine sulfonamide derivatives as chemokine receptor modulators | ASTRAZENECA AB (SE) | 2007-10-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096860-A1 | Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators | CXCR1, CCR5, ACKR3 | POLB 473/4885TSHR 1867/4885KMT2A 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.